0.100
0.00 (1.01%)
前收盘价格 | 0.099 |
收盘价格 | 0.100 |
成交量 | 5,000 |
平均成交量 (3个月) | 125,460 |
市值 | 29,806,702 |
价格/销量 (P/S) | 3.87 |
股市价格/股市净资产 (P/B) | 1.57 |
52周波幅 | |
利润日期 | 29 Jan 2025 - 3 Feb 2025 |
营业毛利率 | -175.04% |
营业利益率 (TTM) | -214.84% |
稀释每股收益 (EPS TTM) | -0.050 |
季度收入增长率 (YOY) | -2.50% |
总债务/股东权益 (D/E MRQ) | 16.18% |
流动比率 (MRQ) | 5.03 |
营业现金流 (OCF TTM) | -14.06 M |
杠杆自由现金流 (LFCF TTM) | -13.11 M |
资产报酬率 (ROA TTM) | -32.72% |
股东权益报酬率 (ROE TTM) | -58.81% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (AU) | 混合的 | 混合的 |
Medical Devices (全球的) | 混合的 | 混合的 | |
股票 | UNI BIOSEN CDI 1:1 [UBI] | - | - |
AIStockmoo 评分
分析师共识 | 0.0 |
内部交易活动 | NA |
价格波动 | 0.5 |
技术平均移动指标 | 0.0 |
技术振荡指标 | -2.5 |
平均 | -0.50 |
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Growth |
内部持股比例 | 10.19% |
机构持股比例 | 42.77% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合